Visual Outcomes and Quality of Vision After Bilateral Implantation of a Hydrophobic Acrylic Trifocal Intraocular Lens.

Abstract

Purpose: To evaluate visual outcomes and quality of vision following bilateral implantation of a hydrophobic acrylic intraocular lens (IOL) in eyes targeted for emmetropia.

Methods: This was a prospective, single arm study. Subjects were bilaterally implanted with the Clareon PanOptix IOL and evaluated at 1 and 3 months postoperatively. Endpoints included binocular uncorrected and distance-corrected visual acuities at distance (UDVA, CDVA), intermediate (UIVA, DCIVA; 60 cm), and near (UNVA, DCNVA; 40 cm, 33 cm), defocus curve, manifest refraction, and administration of a visual disturbance questionnaire (QUVID) and a satisfaction questionnaire (IOLSAT).

Results: A total of 24 subjects (48 eyes) completed the study. Mean postoperative binocular CDVA, DCIVA (60 cm), DCNVA (40 cm), and DCNVA (33 cm) were -0.04 ± 0.08 logMAR, -0.08 ± 0.10 logMAR, 0.01 ± 0.10 logMAR, and 0.04 ± 0.11 logMAR, respectively. Mean postoperative binocular UDVA, UIVA (60 cm), UNVA (40 cm), and UNVA (33 cm) were 0.02 ± 0.19 logMAR, -0.08 ± 0.09 logMAR, 0.04 ± 0.12 logMAR, and 0.08 ± 0.15 logMAR, respectively. Overall, postoperative spectacle independence at distance, intermediate, and near were 100%, 93%, and 73%, respectively. A total of 9%, 12%, and 0% of subjects were bothered "quite a bit" or "very much" by halos, starburst, and glare, respectively.

Conclusion: The results of this study suggest that bilateral implantation with the Clareon PanOptix can achieve excellent visual outcomes, high spectacle independence, and low reports of bothersome dysphotopsia.